Bicocca Open Archive

Logo unimib boa
QUARTI TREVANO, FOSCA ANNA LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.504
AS - Asia 11.510
EU - Europa 7.249
SA - Sud America 1.704
AF - Africa 289
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 11
Totale 37.289
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.842
SG - Singapore 3.857
CN - Cina 2.352
VN - Vietnam 2.156
HK - Hong Kong 1.473
RU - Federazione Russa 1.335
BR - Brasile 1.294
IT - Italia 1.166
DE - Germania 1.164
SE - Svezia 952
IE - Irlanda 675
CA - Canada 518
UA - Ucraina 464
GB - Regno Unito 390
FR - Francia 333
IN - India 329
KR - Corea 242
FI - Finlandia 202
BD - Bangladesh 198
AR - Argentina 148
IQ - Iraq 135
AT - Austria 134
ID - Indonesia 126
TR - Turchia 107
ZA - Sudafrica 97
MX - Messico 81
PK - Pakistan 80
JP - Giappone 75
NL - Olanda 69
ES - Italia 66
PL - Polonia 65
SA - Arabia Saudita 64
PH - Filippine 60
CO - Colombia 57
EC - Ecuador 56
VE - Venezuela 56
DK - Danimarca 43
UZ - Uzbekistan 43
KE - Kenya 32
MY - Malesia 28
EG - Egitto 27
BE - Belgio 25
CZ - Repubblica Ceca 25
TN - Tunisia 25
MA - Marocco 24
PY - Paraguay 24
CL - Cile 23
ET - Etiopia 23
AU - Australia 22
JO - Giordania 20
LT - Lituania 20
AE - Emirati Arabi Uniti 16
NP - Nepal 16
PE - Perù 16
DZ - Algeria 15
AL - Albania 13
AZ - Azerbaigian 13
BO - Bolivia 13
RO - Romania 13
UY - Uruguay 13
IR - Iran 12
CH - Svizzera 11
EE - Estonia 11
JM - Giamaica 11
LB - Libano 11
BG - Bulgaria 10
BY - Bielorussia 10
HN - Honduras 10
KZ - Kazakistan 10
TW - Taiwan 10
HU - Ungheria 9
LK - Sri Lanka 9
MK - Macedonia 9
CR - Costa Rica 8
PS - Palestinian Territory 8
PT - Portogallo 8
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
IL - Israele 7
PA - Panama 7
SN - Senegal 7
GE - Georgia 6
KW - Kuwait 6
NG - Nigeria 6
OM - Oman 6
XK - ???statistics.table.value.countryCode.XK??? 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
KG - Kirghizistan 5
RS - Serbia 5
TH - Thailandia 5
EU - Europa 4
MU - Mauritius 4
NI - Nicaragua 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AO - Angola 3
GR - Grecia 3
HR - Croazia 3
Totale 37.229
Salva come PNG Salva come JPEG
Città #
Singapore 2.227
Ann Arbor 2.182
Ashburn 1.557
Hong Kong 1.447
San Jose 1.095
Fairfield 986
Woodbridge 936
Houston 711
Frankfurt am Main 706
Ho Chi Minh City 650
Dublin 637
Chandler 573
Dallas 523
Hanoi 516
Wilmington 515
Jacksonville 471
Hefei 467
New York 391
Seattle 368
Beijing 357
Toronto 343
Milan 321
Chicago 318
Dearborn 318
Cambridge 307
Santa Clara 289
Los Angeles 276
Princeton 246
Seoul 232
The Dalles 216
Lauterbourg 156
Moscow 150
Shanghai 124
Lawrence 121
Altamura 120
São Paulo 115
Nanjing 114
Vienna 110
Buffalo 96
Da Nang 96
Munich 89
Council Bluffs 88
Orem 84
Helsinki 77
Haiphong 75
Lachine 73
Jakarta 71
San Diego 68
Guangzhou 66
Boardman 60
Atlanta 55
Baghdad 55
London 54
Chennai 53
Rome 52
Lissone 50
Rio de Janeiro 49
Tokyo 49
Warsaw 47
Dong Ket 44
Andover 42
Nuremberg 42
Brooklyn 41
Hangzhou 41
Quận Bình Thạnh 40
Denver 39
Nanchang 38
Tashkent 38
Johannesburg 37
Changsha 36
Turku 36
Ha Long 35
Tianjin 35
Salt Lake City 32
Can Tho 31
Düsseldorf 31
Hebei 31
Hải Dương 31
Montreal 31
Dhaka 30
Phoenix 29
Zhengzhou 28
Mumbai 27
Ninh Bình 27
San Francisco 27
Vũng Tàu 27
Biên Hòa 26
Fremont 25
Thái Nguyên 25
Belo Horizonte 24
Falls Church 24
Jiaxing 24
Kent 24
Brasília 23
Lahore 23
Brussels 22
Jinan 22
Monza 22
Nairobi 22
New Delhi 22
Totale 23.852
Salva come PNG Salva come JPEG
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 470
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 455
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 441
Heart rate as a sympathetic marker during acute adrenergic challenge 426
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 412
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 339
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 326
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 325
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 316
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 312
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 302
Neurogenic abnormalities in masked hypertension 294
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 294
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 291
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 285
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 281
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 280
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: Results of a double-blind randomized multicentre trial 277
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 275
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 274
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 273
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan 268
Heart Rate, Sympathetic Cardiovascular Influences, and The Metabolic Syndrome 266
Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives 266
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 266
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 265
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 263
Threshold and Target for Blood Pressure Lowering in the Elderly 263
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 262
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 262
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS 259
Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives 259
Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique 258
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 257
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 256
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited 254
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 253
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 250
Iron overload exerts sympathoexcitatory effects in men with essential hypertension: microneurogtaphic evidence 249
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study 249
Effects of hypertension and obesity on the sympathetic activation of heart failure patients 243
Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension 243
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 243
Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction 239
Diurnal blood pressure variation and sympathetic activity 239
Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction 239
Behaviour of regional sympathetic nerve traffic in obstructive sleep apnea syndrome 238
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome 235
SYMPATHETIC OVERDRIVE IN THE RESISTANT HYPERTENSIVE PHENOTYPE 235
Should white-coat hypertension in diabetes be treated? Pro 234
Hypertension, antihypertensive treatment and stroke prevention 233
Adrenergic and metabolic effects of bariatric surgey in obese subjects: a longitudinal study 233
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 231
Effects of acute carotid baroreceptor stimulation on sympathetic nerve traffic in resistant and uncontrolled hypertension: a systematic review and meta-analysis 230
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 230
Incident Left Ventricular Hypertrophy in Masked Hypertension 229
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 229
Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension 227
Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up 226
Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) 225
Early sympathetic activation in the initial clinical stages of chronic renal failure 224
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 224
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation 222
Long-term risk of sustained hypertension in white-coat or masked hypertension 216
Baroreflex function in hypertension: consequences for antihypertensive therapy 215
Blood pressure lowering effects of Rimonabant in obesità-related hypertension 214
Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials 214
Early sympathetic activation in mild renal failure 214
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 213
Cardioprotective effects of telmisartan in uncomplicated and complicated hypertension 211
HYT-Hypertension in Turkey: A Cross-Sectional Survey on Blood Pressure Control with Calcium Channel Blockers Alone or Combined with Other Antihypertensive Drugs 209
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study 208
The "J curve" problem revisited: old and new findings 207
Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity 206
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 206
Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings 206
Association Between Arterial Stiffness, High Blood Pressure, and Hypertensive Phenotypes: Insights from the PAMELA Study 204
New onset left atrial dilatation in the general population: A quarter-century follow-up 204
FAILURE OF ANTIHYPERTENSIVE TREATMENT TO RESTORE NORMAL SYMPATHETIC ACTIVITY 204
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 204
Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis 203
Failure of Antihypertensive Treatment to Restore Normal Sympathetic Activity 202
Sympathetic activation in congestive heart failure: an updated overview 202
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 201
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 200
Association between ADRA1A gene and the metabolic syndrome: Candidate genes and functional counterpart in the PAMELA population 198
Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea 198
Blood pressure control in resistant hypertension: new therapeutic options 196
Left ventricular hypertrophy in isolated and dual masked hypertension 196
Sympathetic activation in congestive heart failure: Evidence, consequences and therapeutic implications 194
Salt intake and sympathetic activity - Response 193
The 'neuroadrenergic hypothesis' in hypertension: current evidence 191
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 191
Habitual Regular Coffee Consumption And Arterial Stiffness -Data From The 3rd Pamela Survey 190
Response to sympathetic activity, heart failure, obesity, and metabolic syndrome: Is there any role for obstructive sleep apnea? 190
Essential hypertension and the sympathetic nervous system 189
Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study 188
Blood pressure control and therapeutic modulation of the adrenergic overdrive 187
Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional‐Based Italian Database 186
Diagnostic and Therapeutic Approach to Different Hypertensive Phenotypes According to the 2023 ESH Guidelines 186
Totale 24.660
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.735
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021388 0 0 0 0 0 0 0 0 0 0 140 248
2021/20222.063 165 171 263 201 177 162 110 83 110 128 195 298
2022/20232.814 320 813 274 271 165 453 48 157 159 20 89 45
2023/20242.231 56 56 112 120 298 501 387 74 252 67 51 257
2024/20256.380 321 721 250 268 518 185 299 278 607 979 723 1.231
2025/202615.667 2.287 1.440 1.433 1.748 1.576 825 2.174 752 1.243 1.461 728 0
Totale 37.939